Bruker Corporation BRKR recently announced a collaboration and quality agreement with the medical device company, Accelerate Diagnostics Inc. AXDX. The agreement enables the validation of Bruker’s ...

MONTREAL--(BUSINESS WIRE)-- At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), the companies i2A Canada and Bruker Ltd. announced ...

BREMEN, Germany--(BUSINESS WIRE)-- Bruker today announces multiple placements of MALDI Biotyper systems for rapid, differentiated and cost-effective microbial identification with various local, state ...

Bruker Corporation BRKR launched the new MALDI Biotyper sirius system for all previously FDA-approved assays and research-use-only (RUO) MALDI Biotyper (MBT) reference libraries at the ASM Microbe ...

Bruker has entered into a strategic collaboration for NGS bioinformatics applications in microbiology and infectious disease testing with Ridom GmbH, based in Muenster, Germany. Ridom´s NGS ...

Bruker is pleased to announce that AOAC International has approved the MALDI Biotyper solution for two new Official Methods of Analysis (OMA) for the confirmation and identification of pathogenic and ...

GENEVA--(BUSINESS WIRE)--At the 4 th Congress of European Microbiologists (FEMS 2011), Bruker announces the amendment of its exclusive distribution agreement for clinical microbiology for Bruker’s ...

Bruker’s MALDI Biotyper CA System wins FDA clearance for new software, faster workflows and 549 validated species.

At the KMIS meeting on Dec. 3-5, 2009 in Berlin, Bruker Daltonics announces a framework agreement with Synlab concerning molecular microbial identification based on MALDI-TOF mass spectrometry. Synlab ...

Two applications on the MALDI Biotyper were recently recognized and published as Official Methods of Analysis (OMA) of AOAC INTERNATIONAL for selected pathogens confirmation and identification of ...